| Prolyl-Hydroxylase Inhibitor Stimulates EPO Production in Patients With ESRD - Medscape |
|
|
Medscape "Our results confirm that both the liver and the kidneys retain a significant production capacity for erythropoietin in end-stage renal disease patients," |